医療法人島田クリニック しまだ訪問診療クリニック
Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.
The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →
Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive
01E2410010 +2Location
- Prefecture
- Osaka
- Address
- 大阪市東淀川区上新庄1-2-8ウェルライフ上新庄1階
Plan classification
- Class INot registered
- Class IIThe medium-risk category under the law.
- Class IIIThe low-risk category under the law.
Certified committee for regenerative medicine
- JSCSF再生医療等委員会
- 日本薬事法務学会再生医療等委員会
Public score
51.0/ 100
- A · Review level
- 25.0 / 30
- B · Technologies
- 15.9 / 35
- C · Coverage
- 7.1 / 25
- D · Class I / II technologies
- 2.9 / 10
The public score is calculated from public registration information and does not reflect quality of care. Scoring method →
Registered technologies (3)
Stem cells (all sources) 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 動脈硬化症に対する自己脂肪由来幹細胞を用いた治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
Adipose-derived stem cells 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 動脈硬化症に対する自己脂肪由来幹細胞を用いた治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
NK and immune cells 2
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| GMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®) | NK and immune cells | Class III |
| 全血採血によるGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®Ⅱ) | NK and immune cells | Class III |
Certified committee for regenerative medicine
- JSCSF再生医療等委員会
- 日本薬事法務学会再生医療等委員会
Public document number
01E241001002E260100102E2601005
Plan classification · Certified committee for regenerative medicine · Public document number
| Registered technologies | Plan classification | Certified committee for regenerative medicine | Public document number |
|---|---|---|---|
| 動脈硬化症に対する自己脂肪由来幹細胞を用いた治療 | Class II | JSCSF再生医療等委員会 | 01E2410010 |
| GMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®) | Class III | 日本薬事法務学会再生医療等委員会 | 02E2601001 |
| 全血採血によるGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®Ⅱ) | Class III | 日本薬事法務学会再生医療等委員会 | 02E2601005 |
Other institutions in the same prefecture
- RiyoメディカルクリニックPublic score 51.0
- 医療法人社団わかと会 りんくうメディカルクリニックPublic score 51.0
- 医療法人秀晄会 コムロ美容外科Public score 51.2
- 心斎橋国際クリニックPublic score 51.2
- ReO CLINICPublic score 49.4
- ノリス美容クリニックPublic score 49.4
- 医療法人 鳳翔会 Blu CLINIC. 大阪院Public score 49.4
- 医療法人MY PLACE MY PLACE Beauty ClinicPublic score 49.4